https://sapphiros.com 2026-03-05 weekly 0.5 https://sapphiros.com/who-we-are 2026-03-04 weekly 0.5 https://sapphiros.com/our-products 2026-03-04 weekly 0.5 https://sapphiros.com/our-capabilities 2026-01-30 weekly 0.5 https://sapphiros.com/why-sapphiros 2025-11-13 weekly 0.5 https://sapphiros.com/media 2025-11-16 weekly 0.5 https://sapphiros.com/contact 2026-02-26 weekly 0.5 https://sapphiros.com/privacy-policy 2025-11-18 weekly 0.5 https://sapphiros.com/cookies 2025-11-18 weekly 0.5 https://sapphiros.com/accessibility 2025-11-18 weekly 0.5 https://sapphiros.com/our-products-1 2026-03-17 weekly 0.5 https://sapphiros.com/media/barda-announces-collaboration-with-sapphiros-for-the-development-of-an-otc-single-use-low-cost-digital-antigen-test 2025-12-01 weekly 0.5 https://sapphiros.com/media/sapphiros-announces-a-strategic-agreement-with-roche-providing-roche-access-to-1-billion-lateral-flow-tests-and-access-to-future-molecular-point-of-care-tests 2025-11-20 weekly 0.5 https://sapphiros.com/media/satio-completes-development-testing-of-remotely-controllable-at-home-intradermal-drug-delivery-system 2025-11-15 weekly 0.5 https://sapphiros.com/media/sapphiros-appoints-healthcare-executive-jackson-mcadam-as-chief-financial-officer 2025-11-16 weekly 0.5 https://sapphiros.com/media/sapphiros-launches-now-future-a-new-era-in-personalized-wellness 2025-11-16 weekly 0.5 https://sapphiros.com/media/sapphiros-is-pleased-to-announce-orasure-technologies-inc-secures-strategic-distribution-rights-and-invests-in-sapphiros 2025-11-16 weekly 0.5 https://sapphiros.com/media/sapphiros-and-cencora-formerly-amerisourcebergen-corporation-enter-into-distribution-agreement 2025-11-16 weekly 0.5 https://sapphiros.com/media/satio-receives-funding-from-arpa-h-to-develop-satiorx-a-novel-at-home-remotely-controllable-transdermal-drug-delivery-device 2025-11-16 weekly 0.5 https://sapphiros.com/media/satio-partners-with-barda-drive-to-develop-a-novel-patch-based-ebolavirus-diagnostic 2025-11-16 weekly 0.5 https://sapphiros.com/media/sapphiros-appoints-industry-veteran-andrew-garfield-to-lead-technology-transfer-to-manufacturing 2025-11-16 weekly 0.5 https://sapphiros.com/media/graphenedx-general-graphene-corp-and-sapphiros-enter-into-strategic-partnership-to-industrialize-graphene-based-biosensors-to-revolutionize-point-of-care-and-consumer-diagnostics 2025-11-16 weekly 0.5 https://sapphiros.com/media/sapphiros-awarded-11m-from-nih-radx-tech-to-develop-a-next-generation-molecular-otc-test 2025-11-16 weekly 0.5 https://sapphiros.com/media/sapphiros-taps-teresa-abraham-for-vp-of-scientific-and-technical-affairs 2025-11-16 weekly 0.5 https://sapphiros.com/media/biocrucible-a-sapphiros-company-appoints-per-grufman-as-ceo 2025-11-16 weekly 0.5 https://sapphiros.com/media/sapphiros-appoints-mark-gladwell-as-ceo-and-president 2025-11-16 weekly 0.5 https://sapphiros.com/media/sapphiros-acquires-flexotronix-limited 2025-11-16 weekly 0.5 https://sapphiros.com/media/mike-musgnug-joins-sapphiros-as-executive-vice-president-strategy-and-ceo-graphenedx 2025-11-16 weekly 0.5 https://sapphiros.com/media/satio-and-institut-pasteur-de-dakar-form-strategic-partnership-on-research-development-manufacture-and-distribution-of-next-generation-healthcare-technologies 2025-11-16 weekly 0.5 https://sapphiros.com/media/satio-and-intact-form-strategic-partnership-to-jointly-improve-delivery-of-mass-vaccination 2025-11-16 weekly 0.5 https://sapphiros.com/media/sapphiros-a-next-generation-diagnostics-platform-announces-executive-appointments 2025-11-15 weekly 0.5 https://sapphiros.com/media/gates-foundation-backs-biocrucibles-covid-19-venture 2025-11-15 weekly 0.5